Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Bala

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Clinical Epidemiology|September 22, 1998
Valuing outcomes in health care: a comparison of willingness to pay and quality-adjusted life-yearsM V Bala, L L Wood, G A Zarkin, et al.
Pharmacoeconomics|May 27, 1999
Cost effectiveness of pramipexole in Parkinson's disease in the UST J Hoerger, M V Bala, C Rowland, et al.
Journal of Clinical Epidemiology|October 20, 1999
Are health states "timeless"? The case of the standard gamble methodM V Bala, L L Wood, G A Zarkin, et al.
Pharmacoeconomics|May 7, 1996
Estimating the cost effectiveness of atovaquone versus intravenous pentamidine in the treatment of mild-to-moderate Pneumocystis carinii pneumoniaG A Zarkin, M V Bala, L L Wood, et al.
Circulation|January 11, 2000
Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockadeA M Lincoff, D B Mark, J E Tcheng, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Clinical Epidemiology|September 22, 1998
Valuing outcomes in health care: a comparison of willingness to pay and quality-adjusted life-yearsM V Bala, L L Wood, G A Zarkin, et al.
Pharmacoeconomics|May 27, 1999
Cost effectiveness of pramipexole in Parkinson's disease in the UST J Hoerger, M V Bala, C Rowland, et al.
Journal of Clinical Epidemiology|October 20, 1999
Are health states "timeless"? The case of the standard gamble methodM V Bala, L L Wood, G A Zarkin, et al.
Pharmacoeconomics|May 7, 1996
Estimating the cost effectiveness of atovaquone versus intravenous pentamidine in the treatment of mild-to-moderate Pneumocystis carinii pneumoniaG A Zarkin, M V Bala, L L Wood, et al.
Circulation|January 11, 2000
Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockadeA M Lincoff, D B Mark, J E Tcheng, et al.
Pageof 2